For information on the Patient Council read our flyer and email us at [email protected]
The holy grail of a cure for Parkinson’s disease has been held back for decades by the extreme difficulty of measuring whether proposed new drugs actually improve the patient’s symptoms and daily life.
The EPSRC-funded TORUS research programme (£6.17M, EP/X036146/1 ) aims to solve that problem through a novel platform of sensing technologies for use in patients’ own homes along with an advanced data fusion and machine learning pipeline that measures changes in specific mobility-related behaviours over weeks and months.